Polpharma Group is a high quality European pharma manufacturer and a reputable business partner for pharmaceutical companies worldwide. We grow our presence through B2B activities, including API development and manufacturing in our FDA-approved facility, out-licensing of vertically integrated solutions from API to finished formulation, and contract manufacturing services covering a wide variety of solid and liquid forms. With a broad experience in products’ development, manufacturing and marketing, dedicated R&D, Regulatory and Project Management resources, supported by corporate quality system and service excellence, we deliver tailored solutions to meet your business needs.

Polpharma API is a significant European producer of Active Pharmaceutical Ingredients delivering products to pharmaceutical companies worldwide. We are present on 6 continents, in 60+ countries. We provide a one-stop shop solution of vertically integrated services from API development to FDF formulation and manufacturing, scale-up capabilities based on in-house technologies, to regulatory support. At Polpharma quality comes first. Regular FDA audits enabled us to register and sell a number of APIs in the US market and confirm our reliability and credibility towards our business partners around the world. 

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Meet us at

CPhI & PMEC China 2021

SNIEC, Shanghai, China

16 - 18 December 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info